Biogen Inc. ( BIIB) - Key Metrics
BIIB Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $18.52 | $0.66 | $3.04 | $3.32 |
| 2026Q1 | $16.83 | $2.17 | $4.39 | $4.73 |
| 2025Q4 | $15.54 | -$0.33 | $3.49 | $3.79 |
| 2025Q3 | $16.74 | $3.18 | $8.68 | $8.36 |
| 2025Q2 | $18.13 | $4.35 | $1.10 | $0.99 |
BIIB Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | 81.84 |
| 2026Q1 | 0% | 21.12 |
| 2025Q4 | 0% | -133.33 |
| 2025Q3 | 0% | 11.01 |
| 2025Q2 | 0% | 7.22 |
BIIB Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 1.53% | 0% |
| 2026Q1 | 2.58% | 0% |
| 2025Q4 | 2.15% | 0% |
| 2025Q3 | 5.97% | 0% |
| 2025Q2 | 0.79% | 0% |
BIIB
Price: $225.71
52 week price:
Payout Ratio Range:
Earnings Per Share: 5.63 USD
P/E Ratio: 37.02
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - General
Country: United States
Volume: 789100
Ebitda: 1.6 billionMarket Capitalization: 32.9 billion